Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden

Authors:

Hansson-Hedblom A, Almond C, Borgström F, Sly I, Enkusson D, Troelsgaard Buchholt A and Karlsson L.

Publication type:

Journal article

Publication name:

Cost Effectiveness and Resource Allocation

Citation:

Hansson-Hedblom A, Almond C, Borgström F, Sly I, Enkusson D, Troelsgaard Buchholt A and Karlsson L. Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden. Cost Effectiveness and Resource Allocation. 2018; 16(28):1-12.

 

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies